Early onset PDAC – an analysis of patients under 50 years of age within the German cancer registry

Introduction: Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a 5-year overall survival of less than 13% and is predicted to be the second leading cause of cancer death by 2030. PDAC is a disease of the average population group with median age about 70 years old. But there is an increasing incidence of younger patients. In this study, we aimed to characterize the pancreatic cancer population younger than 50 years.